Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Metformin hydrochloride
Cat. No.:
OB0225LY-0417
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Metformin hydrochloride is a widely used metformin salt, primarily used to affect glucose metabolism.
Synonym:
Metformin HCl; 1, 1-Dimethylbiguanide hydrochloride; N, N-dimethylimidodicarbonimidic diamide; Fluamine; Metiguanide; Dimethylbiguanide; Imidodicarbonimidic diamide, N, N-dimethyl-
CAS No.:
1115-70-4
Compound CID:
4091
Formula:
C4H12ClN5
Formula Weight:
165.63
Specification
Relative Density:
1.36 g/cm3 at 20°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Metformin hydrochloride can be used in diabetes research or play an important role in metabolic disease modeling.
Library Information
Targets:
Kinases
Receptors:
AMPK
Pathways:
Autophagy; PI3K/Akt/mTOR signaling; Chromatin/Epigenetic
Plate Number:
AOCL-6
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
15 mg/mL; 90.56 mM
Water Max Solubility:
193.21 mM
ALogP:
-0.36
HBA_Count:
0
HBD_Count:
2
Rotatable Bond:
3
